Pancuronium and Evista drug interactions - a phase IV clinical study of FDA data
Summary:
We study 27,219 people who take Pancuronium (pancuronium bromide) and Evista (raloxifene hydrochloride). There is no drug interaction reported.
The study analyzes what interactions people have when they take Pancuronium and Evista. It is created by eHealthMe based on reports the from the FDA, and is updated regularly.
What is Pancuronium?
Pancuronium has active ingredients of pancuronium bromide. eHealthMe is studying from 1,328 Pancuronium users. Check the latest studies of Pancuronium.
What is Evista?
Evista has active ingredients of raloxifene hydrochloride. It is often used in osteoporosis. eHealthMe is studying from 25,891 Evista users. Check the latest studies of Evista.
No report is found.
Do you take Pancuronium and Evista?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Pancuronium (1,328 reports)
- Evista (25,891 reports)
How the study uses the data?
The study uses data from the FDA. It is based on pancuronium bromide and raloxifene hydrochloride (the active ingredients of Pancuronium and Evista, respectively), and Pancuronium and Evista (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Weed vs. Demerol, side effect and effectiveness comparison - 2 seconds ago
- Drug interactions of Prolia and Minivelle - 4 seconds ago
- Could Raloxifene Hydrochloride cause Speech Disorder? - 7 seconds ago
- Could Femara cause Breast Cancer Recurrent? - 17 seconds ago
- Could Ultram cause Muscle Contractions Involuntary? - 27 seconds ago
- Drug interactions of Symlin and Ramipril - 30 seconds ago
- Could Ondansetron Hydrochloride cause Mobility Decreased? - 30 seconds ago
- Drug interactions of Tegretol and Ortho Tri-Cyclen - 33 seconds ago
- Could Citalopram Hydrobromide cause Agoraphobia? - 34 seconds ago
- Drug interactions of Vitamin B12 and Riociguat - 39 seconds ago